PTK2 and glioblastoma: The increased Src activity in GBM tumors is also a consequence of the increased activation of proteins upstream of Src (e.g., focal adhesion kinase—FAK), cell surface growth factor receptors (e.g., epidermal growth factor receptor—EGFR), and integrins [7,16].